levetiracetam levetiracetam

Generic: levetiracetam

Labeler: atlantic biologicals corp.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name levetiracetam levetiracetam
Generic Name levetiracetam
Labeler atlantic biologicals corp.
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

levetiracetam 100 mg/mL

Manufacturer
Atlantic Biologicals Corp.

Identifiers & Regulatory

Product NDC 17856-0574
Product ID 17856-0574_3624ffe5-0cb0-b7c0-e063-6394a90a69bf
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203052
Listing Expiration 2026-12-31
Marketing Start 2015-06-11

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 178560574
Hyphenated Format 17856-0574

Supplemental Identifiers

RxCUI
403884
UPC
0331722574471
UNII
44YRR34555
NUI
N0000008486

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name levetiracetam levetiracetam (source: ndc)
Generic Name levetiracetam (source: ndc)
Application Number ANDA203052 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/mL
source: ndc
Packaging
  • 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0574-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-0574-2)
source: ndc

Packages (1)

17856-0574-1 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0574-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-0574-2)

Ingredients (1)

levetiracetam (100 mg/mL)

Linked Drug Pages (1)

Levetiracetam Levetiracetam ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3624ffe5-0cb0-b7c0-e063-6394a90a69bf", "openfda": {"nui": ["N0000008486"], "upc": ["0331722574471"], "unii": ["44YRR34555"], "rxcui": ["403884"], "spl_set_id": ["56fed03f-38c3-4273-8fd7-522bc508bf36"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Atlantic Biologicals Corp."]}, "finished": true, "packaging": [{"sample": false, "description": "72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0574-1)  / 5 mL in 1 CUP, UNIT-DOSE (17856-0574-2)", "package_ndc": "17856-0574-1", "marketing_start_date": "20210825"}], "brand_name": "Levetiracetam Levetiracetam", "product_id": "17856-0574_3624ffe5-0cb0-b7c0-e063-6394a90a69bf", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "17856-0574", "generic_name": "Levetiracetam", "labeler_name": "Atlantic Biologicals Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "brand_name_suffix": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "100 mg/mL"}], "application_number": "ANDA203052", "marketing_category": "ANDA", "marketing_start_date": "20150611", "listing_expiration_date": "20261231"}